Civic Intelligence

T a G Treatment Action Group Inc.

990 • Fiscal year 2017 • EIN 13-3624785

Jan 01, 2017 to Dec 31, 2017 • Filed on Oct 29, 2018

Organization ProfileWWW.TREATMENTACTIONGROUP.ORG
90 Broad Street No 2503New York, NY 10004

(212) 253-7922

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

36th percentile

0.03x

Higher debt load relative to assets than 36% of similar nonprofits.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2017

Liabilities / Revenue

30th percentile

0.03x

Higher debt load relative to revenue than 30% of similar nonprofits.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2017

Net Margin

36th percentile

-0.9%

Higher net margin than 36% of similar nonprofits.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2017

Top Officer Pay

87th percentile

$171,830

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 6.6% of source-year revenue.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2017

Asset Growth

36th percentile

-0.6%

Faster asset growth than 36% of similar nonprofits.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2016 to 2017

Revenue Growth

88th percentile

61%

Faster revenue growth than 88% of similar nonprofits.

2017 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets36th percentile

Assets

Down

$2,575,844

Down $16,374 (-0.6%) from 2016

Net Assets

Down

$2,495,115

Down $23,020 (-0.9%) from 2016

Liabilities

Up

$80,729

Up $6,646 (+9.0%) from 2016

Revenue And Expenses
Liabilities / Revenue30th percentileNet Margin36th percentile

Revenue

Up

$2,619,130

Up $995,458 (+61%) from 2016

Expenses

Down

$2,642,336

Down $47,693 (-1.8%) from 2016

Net Income

Up

-$23,206

Up $1,043,151 (+98%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth36th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2017

Assets$2,575,844
Liabilities$80,729
Net Assets$2,495,115
Open 2017 Filing

Operations Trend

Revenue Growth88th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2017

Revenue$2,619,130
Expenses$2,642,336
Net Income-$23,206
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Oct 29, 2018
Return Version
2017v2.2
Gross Receipts
$2,677,255
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

See schedule o treatment action group, inc. ("tag") is a not-for-profit organization incorporated under the laws of the state of new york. Founded in january 1992, tag is an independent, activist and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for hiv, tuberculosis, and hepatitis c virus. Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. We are science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.the primary sources of revenue to tag are contributions and grants.tag is a nonprofit organization exempt from federal income tax under section 501(c)(3) of the internal revenue code.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$1,946,728$1,936,569▼ $10,159
Accounts Receivable$73,871$88,411▲ $14,540
Land, Buildings, and Equipment, Net$30,870$25,974▼ $4,896
Prepaid Expenses and Deferred Charges$31,826$25,384▼ $6,442
Cash and Non-Interest-Bearing Accounts$31,960$12,543▼ $19,417
Total Assets$2,592,218$2,575,844▼ $16,374
Other Assets Total$476,963$486,963▲ $10,000
Liabilities
Other Liabilities$44,570$55,069▲ $10,499
Accounts Payable and Accrued Expenses$29,513$25,660▼ $3,853
Deferred Revenue$0$0→ $0
Total Liabilities$74,083$80,729▲ $6,646
Net Assets / Fund Balance
Unrestricted Net Assets$1,355,999$1,321,367▼ $34,632
Temporarily Rstr Net Assets$1,162,136$1,173,748▲ $11,612
Total Net Assets Fund Balance$2,518,135$2,495,115▼ $23,020
Total Liabilities and Net Assets / Fund Balance$2,592,218$2,575,844▼ $16,374

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$14,468$47,313$61,781
Other Land Buildings$11,506$7,102$18,608
Other Assets Org$72,463--
Compensation and Service Providers
Top Officer Pay87th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Mark HarringtonExecutive DirectorFT$156,138$15,692$171,830
Scott W Morgan Till July 2017Deputy Executive DirectorFT$49,106$13,311$62,417
Dennis F Giza Started Dec 17Deputy Executive DirectorFT$5,754-$5,754

Board Members and Trustees

NameTitle
Barbara HughesPresident
Alby P Maccarone JrDirector
David I SigalDirector
Dick DadeyDirector
Frank BuaDirector
Jason OsherDirector
Jim AquinoDirector
Joy EpisallaDirector
Kevin GoetzDirector
Monte SteinmanDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Robert W LennonDirector
Roy M Gulick MdmphDirector
Laura MorrisonSecretary/treasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$2,615,931
Program Service Revenue
$0
Investment Income
$1,549
Other Revenue
$1,650
All Other Contributions
$2,320,144
Change in Net Assets
$-23,206

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
No
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Other Non Cash Contri Table3$121,786Selling Value
Works of Art1$45,000Selling Value
Total Noncash Contributions4$166,786-

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,619,130
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$2,619,130
Total Revenue per Form 990
$2,619,130
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,479,176
Other Expenses$1,062,360
Total Fundraising Expense$180,646
Professional Fundraising Fees$68,800
Grants and Similar Amounts Paid$32,000

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$821,513$107,151$10,411$939,075
Fees for Services Other$129,173$87,578$55,192$271,943
Conferences and Meetings$235,262$5,999$26$241,287
Current Officers, Directors, Trustees, and Key Employees$179,311$49,499$11,191$240,001
Other Employee Benefits$197,067$14,630$3,812$215,509
Occupancy$160,990$29,567-$190,557
Travel$158,525$1,242$192$159,959
Office Expenses$81,762$8,226$16,390$106,378
Payroll Taxes$73,030$11,368$193$84,591
Fees for Services Professional Fundraising--$68,800$68,800
Grants to Domestic Orgs$30,000--$30,000
Information Technology$16,288$1,753-$18,041
Fees for Services Accounting-$18,000-$18,000
Insurance$8,604$1,722-$10,326
Other Expenses$2,068$6,293$1,804$10,165
Depreciation Depletion-$9,432-$9,432
Fees for Services Legal-$7,564-$7,564
Fees for Services Lobbying$6,073--$6,073
Foreign Grants$2,000--$2,000
Total Functional Expenses$2,101,666$360,024$180,646$2,642,336

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,642,336
Total Expenses per Audited Statements$2,642,336
Total Expenses per Form 990$2,642,336
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Act UpNew York, NY-Advocacy$30,000

International Summary

Offices
0
Employees
0
Spending
$204,281

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
RussiaProgram ServicesTB/HIV:GATES APR17>DEC17--$35,580
BelgiumProgram ServicesTB/HIV:GATES APR17>DEC17--$27,097
RussiaProgram ServicesTB/HIV:GDF/STBP--$19,955
MexicoProgram ServicesTB/HIV:GATES APR17>DEC17--$16,023
FranceProgram ServicesHIV ANTIRETROVIRALS:GILEAD TAGLINE PIPELINE & ETE--$15,076
FranceProgram ServicesTB/HIV:GATES APR17>DEC17--$9,168
FranceProgram ServicesADMINISTRATION:ADMIN - GEN OPS--$6,444
MexicoProgram ServicesTB/HIV:STOPTB SYMPOSIUM OCT17--$6,420
AustraliaProgram ServicesTb/hiv--$4,203
NetherlandsProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$4,056
FranceProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$3,872
NetherlandsProgram ServicesTB/HIV:TBHIV - GENOPS--$3,489
South AfricaProgram ServicesTB/HIV:GATES APR17>DEC17--$3,260
CanadaProgram ServicesTB/HIV:GATES APR17>DEC17--$3,124
MexicoProgram ServicesTB/HIV:STOPTB R&DREPORT APR17>DEC17--$3,021
MexicoProgram ServicesTB/HIV:HARVARD SYMPOSIUM--$2,768
BrazilProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$2,763
ThailandProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$2,528
MexicoProgram ServicesTB/HIV:CRAG VA OCT16>SEPT17--$2,479
BulgariaProgram ServicesTB/HIV:GATES APR17>DEC17--$2,400
FranceProgram ServicesHIV ANTIRETROVIRALS:ELTONJOHNAIDS CURE NOV16>OCT17--$2,358
FranceProgram ServicesHCV HEPATITIS:MERCK MISSION SUPPORT *--$2,075
ThailandProgram ServicesTB/HIV:STOPTB - BANGKOK--$2,008
SpainProgram ServicesTB/HIV:TBHIV - GENOPS--$1,822
SwirzerlandProgram ServicesHIV ANTIRETROVIRALS:EJAF SOUTHERN STATES INITIATIVE--$1,732
FranceProgram ServicesHIV ANTIRETROVIRALS:JANSSEN TAGLINE & PIPELINE--$1,549
CanadaProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$1,535
KenyaProgram ServicesTB/HIV:GDF/STBP--$1,500
NetherlandsProgram ServicesHCV HEPATITIS:HCV - GENOPS--$1,304
ThailandProgram ServicesTB/HIV:GATES APR17>DEC17--$1,269
RussiaProgram ServicesTB/HIV:WHO R&DREPORT MARCH17>DEC17--$1,228
UkProgram ServicesTB/HIV:GATES APR17>DEC17--$1,205
CanadaProgram ServicesTB/HIV:GATES:GATES 2 OCT16>MARCH17--$1,149
AustraliaProgram ServicesHCV HEPATITIS:OPENSOCIETYFDN LMIC ADVOCACY--$1,020
BelgiumProgram ServicesTB/HIV:GATES:GATES 1 OCT16>MARCH17--$983
BelgiumProgram ServicesTB/HIV:GATES:GATES 2 OCT16>MARCH17--$983
BelgiumProgram ServicesTB/HIV:GATES:GATES 3 OCT16>MARCH17--$983
CanadaProgram ServicesTB/HIV:CRAG VA OCT16>SEPT17--$806
CanadaProgram ServicesHCV HEPATITIS:HCV - GENOPS--$732
IndiaProgram ServicesTB/HIV:GATES APR17>DEC17--$641
SwitzerlandProgram ServicesTB/HIV:GATES APR17>DEC17--$593
FranceProgram ServicesHCV HEPATITIS:HCV - GENOPS--$537
FranceProgram ServicesHCV HEPATITIS:LEVISTRAUSS2017--$500
IcelandProgram ServicesTB/HIV:GATES APR17>DEC17--$378
FranceProgram ServicesHIV ANTIRETROVIRALS:FORD ETE&COMMUNITYMOBILIZATIION--$337
NetherlandsProgram ServicesTB/HIV:GATES APR17>DEC17--$273
UkProgram ServicesTB/HIV:UNITAID - AURUM:PH I--$269
SwitzerlandProgram ServicesHCV HEPATITIS:HCV - GENOPS--$237
CanadaProgram ServicesTB/HIV:WHO R&DREPORT MARCH17>DEC17--$201
BelgiumProgram ServicesAdministration--$198
ZimbabweProgram ServicesTB/HIV:GDF/STBP--$150
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
Yes

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$68,800
Fundraising Gross Income$59,775
Fundraising Direct Expenses$58,125

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$280,562$59,775-$59,775
Total Events$280,562$59,775$58,125$1,650
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent$55,069
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of trustees before the return was filed with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”

Form 990, Part VI, Section B, Line 15

“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in 2017.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET NO 2503, NEW YORK, NY 10004

Signing Officer

Name
Laura Morrison
Title
Secretary/treasurer
Phone
2122537922
Signed
2018-10-29
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Laura Morrison
Formed
1992
Legal Domicile
Ny
Voting Board Members
16
Independent Board Members
16
Employees
17
Volunteers
17

Preparer

Firm
Loeb & Troper Llp
Address
655 THIRD AVENUE 12TH FLOOR, NEW YORK, NY 10017
Preparer
Aaron Shapiro
Phone
2128674000
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Payroll services: program service expenses 0. Management and general expenses 7,264. Fundraising expenses 0. Total expenses 7,264. It services: program service expenses 981. Management and general expenses 2,044. Fundraising expenses 0. Total expenses 3,025. Temp services: program service expenses 21,906. Management and general expenses 71,395. Fundraising expenses 2,412. Total expenses 95,713. Editing and design services: program service expenses 52,280. Management and general expenses 0. Fundraising expenses 0. Total expenses 52,280. Consultant: program service expenses 54,006. Management and general expenses 6,875. Fundraising expenses 52,780. Total expenses 113,661.”

FORM 990, PART XI, LINE 9:

“Gain on disposal of fixed assets 186.”

Part XII Line 2C

“The process has not changed since the prior year.”

Financial Statement Notes

PART III, LINE 4:

“The art prints are sold as part of the ticket package for major donors of the research in action awards event, and subsequently sold as individual editions.”

PART X, LINE 2:

“Tag has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements. Periods ending december 31, 2014 and subsequent remain subject to examination by applicable taxing authorities.”

Raw XML AppendixShowing 400 of 859 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt029513
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt025660
IRS990/AccountsReceivableGrp/BOYAmt073871
IRS990/AccountsReceivableGrp/EOYAmt088411
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE SCHEDULE O TREATMENT ACTION GROUP, INC. ("TAG") IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED UNDER THE LAWS OF THE STATE OF NEW YORK. FOUNDED IN JANUARY 1992, TAG IS AN INDEPENDENT, ACTIVIST AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK FIGHTING FOR BETTER TREATMENT, PREVENTION, A VACCINE, AND A CURE FOR HIV, TUBERCULOSIS, AND HEPATITIS C VIRUS. TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. WE ARE SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.THE PRIMARY SOURCES OF REVENUE TO TAG ARE CONTRIBUTIONS AND GRANTS.TAG IS A NONPROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE.
IRS990/AllOtherContributionsAmt02320144
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0CHRISTOPHER GEORGE
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET RM 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt031960
IRS990/CashNonInterestBearingGrp/EOYAmt012543
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt011191
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt049499
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0179311
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0240001
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/FundraisingAmt026
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt05999
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0235262
IRS990/ConferencesMeetingsGrp/TotalAmt0241287
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0220787
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02615931
IRS990/CYGrantsAndSimilarPaidAmt032000
IRS990/CYInvestmentIncomeAmt01549
IRS990/CYOtherExpensesAmt01062360
IRS990/CYOtherRevenueAmt01650
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-23206
IRS990/CYSalariesCompEmpBnftPaidAmt01479176
IRS990/CYTotalExpensesAmt02642336
IRS990/CYTotalFundraisingExpenseAmt0180646
IRS990/CYTotalProfFndrsngExpnsAmt068800
IRS990/CYTotalRevenueAmt02619130
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd01
IRS990/DeductibleNonCashContriInd01
IRS990/DeferredRevenueGrp/BOYAmt00
IRS990/DeferredRevenueGrp/EOYAmt00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt09432
IRS990/DepreciationDepletionGrp/TotalAmt09432
IRS990/Desc0SEE SCHEDULE OTB/HIV PROJECT:ACCORDING TO THE WHO 2018 REPORT, TUBERCULOSIS (TB), THE WORLD'S DEADLIEST INFECTIOUS DISEASE AND ONE OF THE TOP TEN GLOBAL CAUSES OF MORTALITY, CAUSED 10 MILLION NEW CASES IN 2017, CAUSING 1.6 MILLION DEATHS, 300,000 OF THEM AMONG PEOPLE LIVING WITH HIV. DESPITE BEING CURABLE, IT IS THE LEADING CAUSE OF DEATH FOR HIV-POSITIVE PEOPLE GLOBALLY. HIV SIGNIFICANTLY INCREASES THE RISK FOR DEVELOPING TB DISEASE. PEOPLE AT RISK FOR BOTH DISEASES REQUIRE TB AND HIV SERVICES THAT WORK TOGETHER. TAG'S TB/HIV PROJECT STRENGTHENS COMMUNITY-DRIVEN ADVOCACY FOR BETTER TB AND TB/HIV RESEARCH, AND HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE. THE PROJECT EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB/HIV COINFECTION AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROJECT WORKS WITH RESEARCHERS, COMMUNITY ADVOCATES, POLICY MAKERS, AND GLOBAL COALITIONS TO INCREASE THE QUANTITY AND IMPROVE THE QUALITY OF RESEARCH THAT CAN LEAD TO SHORTER, EASIER TB TREATMENT, MORE ACCURATE DIAGNOSTICS, AND BETTER PREVENTIVE OPTIONS. THE TB/HIV PROJECT CONVENES AND ORGANIZES THE GLOBAL TB COMMUNITY ADVISORY BOARD (TB CAB), A GROUP OF EXPERT, EXPERIENCED COMMUNITY MEMBERS WHO PARTICIPATE ACTIVELY IN ONGOING CONSULTATIONS WITH SPONSORS, FUNDERS, AND ORGANIZERS OF TB PRODUCTS IN DEVELOPMENT, PARTICULARLY NEW TREATMENTS, NEW REGIMENS, AND NEW DIAGNOSTIC TEST PLATFORMS AND ALGORITHMS. THE PROJECT REGULARLY ADVISES AND CONSULTS WITH THE WORLD HEALTH ORGANIZATION (WHO) END TB PROGRAMME, THE STOP TB PARTNERSHIP, UNAIDS, UNITAID, THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA, THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), THE FOOD AND DRUG ADMINISTRATION (FDA), THE NATIONAL INSTITUTES OF HEALTH (NIH) AND PARTICULARLY ITS NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) AND OFFICE OF AIDS RESEARCH, THE OFFICE OF THE GLOBAL AIDS COORDINATOR (OGAC) AND ITS SCIENTIFIC ADVISORY BOARD, USAID, AND TB RESEARCH NETWORKS AND CONSORTIA SUCH AS THE AIDS CLINICAL TRIALS GROUP (ACTG), THE INTERNATIONAL MATERNAL PEDIATRIC AND ADOLESCENT AIDS CLINICAL TRIALS (IMPAACT) NETWORK, THE TB TRIALS CONSORTIUM (TBTC), AND OTHERS ON RESEARCH AGENDA, STUDY DESIGN, IMPLEMENTATION, ANALYSIS, DISSEMINATION OF RESULTS, AND THEIR TRANSLATION INTO POLICIES AND PROGRAMS.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt017
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0986264
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt018000
IRS990/FeesForServicesAccountingGrp/TotalAmt018000
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt07564
IRS990/FeesForServicesLegalGrp/TotalAmt07564
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt06073
IRS990/FeesForServicesLobbyingGrp/TotalAmt06073
IRS990/FeesForServicesOtherGrp/FundraisingAmt055192
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt087578
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0129173
IRS990/FeesForServicesOtherGrp/TotalAmt0271943
IRS990/FeesForServicesProfFundraising/FundraisingAmt068800
IRS990/FeesForServicesProfFundraising/TotalAmt068800
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt02000
IRS990/ForeignGrantsGrp/TotalAmt02000
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt09.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.60
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.05
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.60
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.05
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt121.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt130.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.40
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt150.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1840.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1615692
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1713311
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA HUGHES
IRS990/Form990PartVIISectionAGrp/PersonNm1LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm2JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm3FRANK BUA
IRS990/Form990PartVIISectionAGrp/PersonNm4DICK DADEY
IRS990/Form990PartVIISectionAGrp/PersonNm5NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm6JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm7KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm8ROY M GULICK MDMPH
IRS990/Form990PartVIISectionAGrp/PersonNm9ROBERT W LENNON
IRS990/Form990PartVIISectionAGrp/PersonNm10RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm11ALBY P MACCARONE JR
IRS990/Form990PartVIISectionAGrp/PersonNm12ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm13JASON OSHER
IRS990/Form990PartVIISectionAGrp/PersonNm14DAVID I SIGAL
IRS990/Form990PartVIISectionAGrp/PersonNm15MONTE STEINMAN
IRS990/Form990PartVIISectionAGrp/PersonNm16MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm17SCOTT W MORGAN TILL JULY 2017
IRS990/Form990PartVIISectionAGrp/PersonNm18DENNIS F GIZA STARTED DEC 17
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt16156138
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1749106
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt185754
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY/TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt17DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt18DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0220787
IRS990/FundraisingDirectExpensesAmt058125
IRS990/FundraisingGrossIncomeAmt059775
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt016
IRS990/GovernmentGrantsAmt075000
IRS990/GrantAmt02000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt030000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt030000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt02677255
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt016
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01753
IRS990/InformationTechnologyGrp/ProgramServicesAmt016288
IRS990/InformationTechnologyGrp/TotalAmt018041
IRS990/InsuranceGrp/ManagementAndGeneralAmt01722
IRS990/InsuranceGrp/ProgramServicesAmt08604
IRS990/InsuranceGrp/TotalAmt010326
IRS990/InvestmentIncomeGrp/ExclusionAmt01549
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01549
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt011
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt054415
IRS990/LandBldgEquipBasisNetGrp/BOYAmt030870
IRS990/LandBldgEquipBasisNetGrp/EOYAmt025974
IRS990/LandBldgEquipCostOrOtherBssAmt080389
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. WE ARE SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt02518135
IRS990/NetAssetsOrFundBalancesEOYAmt02495115
IRS990/NetIncmFromFundraisingEvtGrp/ExclusionAmt01650
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt01650
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoncashContributionsAmt0166786
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt029567
IRS990/OccupancyGrp/ProgramServicesAmt0160990
IRS990/OccupancyGrp/TotalAmt0190557
IRS990/OfficeExpensesGrp/FundraisingAmt016390
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt08226
IRS990/OfficeExpensesGrp/ProgramServicesAmt081762
IRS990/OfficeExpensesGrp/TotalAmt0106378
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0476963
IRS990/OtherAssetsTotalGrp/EOYAmt0486963
IRS990/OtherChangesInNetAssetsAmt0186
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt03812
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt014630
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0197067
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0215509
IRS990/OtherExpensesGrp/Desc0DIRECT MAIL EXPENSES
IRS990/OtherExpensesGrp/Desc1OTHER
IRS990/OtherExpensesGrp/FundraisingAmt012635
IRS990/OtherExpensesGrp/FundraisingAmt11804
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt06293
IRS990/OtherExpensesGrp/ProgramServicesAmt02068
IRS990/OtherExpensesGrp/TotalAmt012635
IRS990/OtherExpensesGrp/TotalAmt110165
IRS990/OtherLiabilitiesGrp/BOYAmt044570
IRS990/OtherLiabilitiesGrp/EOYAmt055069
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt010411
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0107151
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0821513
IRS990/OtherSalariesAndWagesGrp/TotalAmt0939075
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt0193
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt011368
IRS990/PayrollTaxesGrp/ProgramServicesAmt073030
IRS990/PayrollTaxesGrp/TotalAmt084591
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt031826
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt025384
IRS990/PrincipalOfficerNm0LAURA MORRISON
IRS990/ProfessionalFundraisingInd01
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHIV PROJECT:IN 2017, ACCORDING TO THE SEPTEMBER 2018 UNAIDS GLOBAL AIDS UPDATE, 36.9 MILLION PEOPLE WERE LIVING WITH HIV, 1.8 MILLION BECAME NEWLY INFECTED, AND 940,000 PEOPLE DIED FROM AIDS - THE LOWEST NUMBER IN THIS CENTURY. AN ESTIMATED 21.7 MILLION PEOPLE LIVING WITH HIV WERE RECEIVING LIFE-SAVING ANTIRETROVIRAL THERAPY. THIS IMMENSE PUBLIC HEALTH FAILURE CAN BE ATTRIBUTED TO A DENSE WEB OF MEDICAL, POLITICAL, AND ECONOMIC PROBLEMS. THE VAST MAJORITY OF THE WORLD'S PEOPLE LIVING WITH HIV RESIDE IN DEVELOPING COUNTRIES WHERE MANY OBSTACLES PREVENT THE WIDESPREAD DISTRIBUTION OF HIV DRUGS. BUT EVEN THE MOST EFFECTIVE EXISTING DRUGS HAVE SHORTCOMINGS, AND PEOPLE LIVING WITH HIV EVERYWHERE NEED BETTER TREATMENT STRATEGIES AND, ULTIMATELY, A CURE - ONE THAT CAN BE USED WORLDWIDE TO END THE EPIDEMIC ALONG WITH A SAFE AND EFFECTIVE HIV VACCINE. TAG'S HIV PROJECT REVIEWS THE STATE OF RESEARCH ON ANTIRETROVIRAL DRUG DISCOVERY, DEVELOPMENT, DISSEMINATION, AND POSTMARKETING SURVEILLANCE. THE HIV PROJECT ADVOCATES FOR ACCELERATED ACCESS TO TREATMENTS; INNOVATION IN THE DEVELOPMENT OF TREATMENTS THAT ARE ACTIVE AGAINST DRUG-RESISTANT HIV; AND DEVELOPMENT OF HIV TREATMENTS THAT ARE EASIER TO TAKE, ASSOCIATED WITH FEWER SIDE EFFECTS, AND AFFORDABLE TO HEALTH CARE SYSTEMS AND PEOPLE LIVING WITH HIV.TAG'S HIV PROJECT WORKS WITH COMMUNITY MEMBERS, SCIENTISTS, AND POLICY MAKERS TO ENHANCE PUBLIC UNDERSTANDING OF THE SCIENCE OF HIV INFECTION, ADDRESS GAPS IN HIV RESEARCH, CRITIQUE RESEARCH EFFORTS, AND FOSTER CROSS-DISCIPLINARY COLLABORATIONS WITH THE AIM OF ACCELERATING RESEARCH ON HIV PATHOGENESIS AND THE DEVELOPMENT OF EFFECTIVE IMMUNE-BASED THERAPIES AND PREVENTIVE TECHNOLOGIES, WITH A PARTICULAR FOCUS ON RESEARCH ADVOCACY AROUND A CURE FOR HIV. PROJECT STAFF ALSO WORKS ON DOMESTIC AND INTERNATIONAL TREATMENT GUIDELINES TO ENSURE THAT FORMULARY DETERMINATIONS AND PRESCRIBING PRACTICES ARE DRIVEN BY SOUND SCIENTIFIC DATA. THE HIV PROJECT TRACKS AND ANALYZES RESOURCES DEVOTED TO HIV PREVENTION AND COMBINED PREVENTION TECHNOLOGIES. THE PROJECT ADVOCATES FOR LOCAL, STATE, AND NATIONAL AGENCIES AND AIDS SERVICE ORGANIZATIONS TO HAVE INCREASED AWARENESS OF CURRENT PREVENTION TOOLS, ALONG WITH MYRIAD STRUCTURAL BARRIERS SLOWING THEIR UPTAKE, IN ORDER TO STOP TRANSMISSION OF HIV AND THUS END THE EPIDEMIC. PROJECT MEMBERS WORK ON NEW YORK STATE GOVERNOR ANDREW M. CUOMO'S ENDING THE EPIDEMIC STRATEGY AND SERVE ON ITS ENDING THE EPIDEMIC SUBCOMMITTEE OF THE AIDS ADVISORY COUNCIL. THIS EFFORT IS PART OF A BROADER PROJECT BY COMMUNITY ACTIVISTS, POLICY MAKERS, ADVOCATES, AND RESEARCHERS TO END THE EPIDEMIC BY STEMMING NEW INFECTIONS AND ENSURING THAT HIV-POSITIVE PEOPLE RECEIVE CARE, ARE RETAINED IN ACTIVE CARE, AND REMAIN VIRALLY SUPPRESSED. IN EARLY 2017, TAG'S HIV PROJECT COMPLETED A LANDMARK REVIEW OF THE MECHANISMS AND BARRIERS OF EFFECTIVE COMMUNITY MOBILIZATION IN NINE HEAVILY AFFECTED METROPOLITAN AREAS, WHICH WILL SERVE AS A CORNERSTONE OF TAG'S WORK TO STRENGTHEN AND SUPPORT LOCAL ADVOCACY IN THE YEARS AHEAD. IN 2017, TAG CONVENED A GROUP OF PUBLIC HEALTH OFFICIALS, ACTIVISTS, AND COMMUNITY-BASED ORGANIZATIONS FROM JURISDICTIONS ACROSS THE DEEP SOUTH TO BRAINSTORM AND STRATEGIZE ON DEVELOPING STATE- AND CITY-LEVEL PLANS TO END AIDS IN THESE HIGHLY-AFFECTED PARTS OF THE UNITED STATES.FINALLY, THE HIV PROJECT WORKS WITH GLOBAL AND DOMESTIC PARTNERS FOR UNIVERSAL ACCESS TO HIGH-QUALITY HIV PREVENTION, TREATMENT, AND CARE PROGRAMS.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0789763
IRS990/ProgSrvcAccomActy2Grp/GrantAmt030000
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OACCORDING TO THE WORLD HEALTH ORGANIZATION, 71 MILLION PEOPLE WORLDWIDE WERE LIVING WITH CHRONIC HEPATITIS C VIRUS (HCV INFECTION) IN 2017; 399,000 PEOPLE DIED FROM HCV, AND AN ESTIMATED 2.3 MILLION PEOPLE LIVING WITH HIV WERE CO-INFECTED WITH HCV. JUST 20% OF PEOPLE LIVING WITH HCV KNOW THEIR INFECTION STATUS, AND ONLY 2.8 MILLION OF THEM HAVE STARTED CURATIVE HCV TREATMENT. GLOBALLY, AT LEAST 2.3 MILLION PEOPLE LIVING WITH HIV ARE COINFECTED WITH THE HEPATITIS C VIRUS (HCV), WHILE ACCORDING TO THE WORLD HEALTH ORGANIZATION 2017 REPORT, 71 MILLION ARE LIVING WITH CHRONIC HCV INFECTION. OF THOSE, 1.3 MILLION ARE PEOPLE WHO INJECT DRUGS. HIV WORSENS HCV DISEASE PROGRESSION AND OUTCOMES. TAG'S HEPATITIS C VIRUS PROJECT REVIEWS THE STATE OF RESEARCH ON HCV MONOINFECTION AND COINFECTION. IT ADVOCATES FOR BETTER CLINICAL TRIAL DESIGNS, AND ACCESS TO CURATIVE TREATMENT FOR ALL AFFECTED COMMUNITIES, AND IT CONTINUALLY MONITORS STANDARDS OF CARE FOR PEOPLE WITH HCV MONOINFECTION AND COINFECTION. THE PROJECT WORKS IN COLLABORATION WITH THE HCV AND HIV COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFESAVING INFORMATION AND CURATIVE HEPATITIS TREATMENTS UNIVERSALLY AVAILABLE. SINCE THE INTRODUCTION OF ALL-ORAL, SHORT-COURSE DIRECT-ACTING ANTIVIRALS (DAAS), TAG HAS COLLABORATED WITH PARTNERS GLOBALLY AND DOMESTICALLY TO EXPEDITE UNIVERSAL, AFFORDABLE ACCESS TO THESE TREATMENTS. TAG'S HEPATITIS PROJECT HAS BEEN AT THE FOREFRONT OF A GLOBAL AND DOMESTIC HCV TREATMENT ACCESS EDUCATION AND ADVOCACY MOVEMENT. THE PROJECT HAS BEEN INSTRUMENTAL IN BUILDING A GLOBAL COALITION OF ACTIVISTS IN LOW- AND MIDDLE-INCOME COUNTRIES WHO ARE ADVOCATING FOR ACCESS TO THESE CURES AND FOR CARE FOR ALL PEOPLE WITH HCV. HOWEVER, DUE TO DISEASE PROGRESSION, SOBRIETY, AND ADHERENCE RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, PRICING BARRIERS, LIMITED VOLUNTARY LICENSING BY ORIGINATOR COMPANIES, AND DELAYS IN DRUG REGISTRATION, MOST COUNTRIES CANNOT AFFORD TO INITIATE TREATMENT PROGRAMS WITH DAAS. WITHOUT ACCESS TO AFFORDABLE, HIGH-QUALITY GENERIC DAAS, GLOBAL TARGETS TO REDUCE HCV INCIDENCE AND MORTALITY WILL BE UNATTAINABLE. MOST PEOPLE IN NEED OF HCV TREATMENT WILL REMAIN UNTREATED, WHICH PERMITS HCV TO CONTINUE TO SPREAD. TAG'S TREATMENT ACTIVISM SHARES CAMPAIGN STRATEGIES AND ADVOCACY TOOLS WITH PARTNERS DOMESTICALLY AND IN AROUND THE WORLD.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0325639
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01613585
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt024106
IRS990/PYInvestmentIncomeAmt01885
IRS990/PYOtherExpensesAmt01045190
IRS990/PYOtherRevenueAmt08202
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-1066357
IRS990/PYSalariesCompEmpBnftPaidAmt01620733
IRS990/PYTotalExpensesAmt02690029
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01623672
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-23206
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01946728
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01936569
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0HONORARIA INCOME AND TRAVEL REIMBURSEMENT
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02615931
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01611085
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02294240
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt04468799
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01490224
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt012480279
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt01549
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01885
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt02096
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt02457
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt02815
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt010802
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt028381
IRS990ScheduleA/OtherIncome170Grp/TotalAmt028381
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.54730
IRS990ScheduleA/PublicSupportPY170Pct00.53210
IRS990ScheduleA/PublicSupportTotal170Amt06851454
IRS990ScheduleA/SubstantialContributorsTotAmt05628825
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02615931
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01611085
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02294240
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt04468799
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01490224
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt012480279
IRS990ScheduleA/TotalSupportAmt012519462
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/DirectContactLegislatorsAmt06073
IRS990ScheduleC/DirectContactLegislatorsInd01
IRS990ScheduleC/GrantsOtherOrganizationsInd00
IRS990ScheduleC/MailingsMembersInd00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$2,575,844
Liabilities
$80,729
Net assets
$2,495,115
Revenue
$2,619,130
Expenses
$2,642,336
Net income
-$23,206
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29